CPC
UTHR icon

Cookson Peirce & Co’s United Therapeutics UTHR Stock Holding History

Cookson Peirce & Co’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48M Buy
2,727
+302
+12% +$170K 0.05% 183
2026
Q1 		$1.44M Buy
2,425
+1,814
+297% +$903K 0.06% 151
2025
Q4 		$298K Sell
611
-587
-49% -$273K 0.01% 277
2025
Q3 		$502K Buy
1,198
+283
+31% +$95.2K 0.02% 234
2025
Q2 		$263K Buy
+915
New +$273K 0.01% 251
2023
Q1 		– Sell
-4,836
Closed -$1.34M – 260
2022
Q4 		$1.34M Sell
4,836
-360
-7% -$90.9K 0.09% 88
2022
Q3 		$1.09M Buy
5,196
+43
+0.8% +$9.61K 0.08% 98
2022
Q2 		$1.21M Buy
+5,153
New +$1.05M 0.08% 95
2022
Q1 		– Sell
-3,680
Closed -$795K – 249
2021
Q4 		$795K Buy
3,680
+258
+8% +$50.6K 0.04% 125
2021
Q3 		$632K Buy
3,422
+277
+9% +$54.6K 0.04% 137
2021
Q2 		$564K Buy
3,145
+202
+7% +$38.5K 0.04% 146
2021
Q1 		$492K Buy
+2,943
New +$491K 0.03% 126
2015
Q4 		– Sell
-2,925
Closed -$384K – 160
2015
Q3 		$384K Sell
2,925
-1,321
-31% -$212K 0.06% 112
2015
Q2 		$739K Buy
4,246
+40
+1% +$7.2K 0.12% 90
2015
Q1 		$725K Buy
4,206
+530
+14% +$80.8K 0.13% 90
2014
Q4 		$476K Buy
+3,676
New +$474K 0.1% 97
2014
Q2 		– Sell
-37,300
Closed -$3.51M – 164
2014
Q1 		$3.51M Sell
37,300
-1,555
-4% -$159K 0.88% 40
2013
Q4 		$4.39M Buy
+38,855
New +$3.5M 1.16% 29

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Cookson Peirce & Co's UTHR Position: Q2 2026 in Review

Cookson Peirce & Co increased its United Therapeutics (UTHR) stake by 12% in Q2 2026, buying an estimated $170K and bringing the position to 2,727 shares worth $1.48M. The position accounts for 0.05% of the portfolio, ranked #183.

Cookson Peirce & Co first reported a position in UTHR in Q4 2013 and has held it in 18 quarters since. The position peaked at $4.39M in Q4 2013. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Cookson Peirce & Co held 2,727 shares of United Therapeutics worth $1.48M as of Q2 2026.
  • Cookson Peirce & Co bought 302 United Therapeutics shares in Q2 2026, an estimated $170K.
  • United Therapeutics made up 0.05% of Cookson Peirce & Co's portfolio in Q2 2026, its #183 holding.
  • Cookson Peirce & Co first reported a position in United Therapeutics in Q4 2013 and has held it in 18 quarters since.
  • Cookson Peirce & Co's United Therapeutics position peaked at $4.39M in Q4 2013.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Cookson Peirce & Co's 13F filing for Q2 2026, filed 23 Jul 2026.